How To Save A Life: CV Therapeutics Revamps R&D, Ranexa Sales Focus
Firm says it will seek a partner to help detail Ranexa to internal medicine and primary care physicians if granted FDA approval for expanded labeling based on MERLIN results.
Firm says it will seek a partner to help detail Ranexa to internal medicine and primary care physicians if granted FDA approval for expanded labeling based on MERLIN results.